Missed a GLP-1 Dose? Separate a Late Injection From a Treatment Restart

A late weekly injection and restarting after several missed weeks require different questions. First identify your exact product, when you last took it and when the next dose was scheduled. Wegovy injection and Zepbound use different timing rules; a general instruction for “GLP-1s” can miss that distinction.

This guide summarizes the manufacturers’ current prescribing information checked October 25, 2026. It helps you prepare a conversation with your pharmacist or prescriber. It does not select a dose, clear a restart or replace the instructions for your own prescription. The timing below applies to these approved brands, not compounded semaglutide or tirzepatide.

One missed dose: the two brands count time differently

For Wegovy injection, section 2.4 measures the time remaining before the next scheduled injection. When that next dose is more than two days away, the label directs taking the missed dose as soon as possible. When it is less than two days away, the instruction is to skip the missed dose and return on the usual weekly day.¹

For Zepbound, section 2.3 measures time elapsed since the missed dose. It allows the missed injection within four days, or 96 hours. After that window, it directs skipping that injection and returning on the scheduled day. The label also requires at least three days, or 72 hours, between doses when changing the weekly administration day.²

The distinction is the clock you check: time until the next Wegovy injection versus time since the missed Zepbound injection. These are summaries of labeling, not permission to take an extra injection. If your dates are uncertain, you already took a late dose, or you are at a boundary the instructions do not clearly resolve, ask your pharmacist before acting. In particular, Wegovy’s section 2.4 describes more than and less than two days; do not guess at exactly 48 hours.

Several missed weeks need a restart conversation

Wegovy’s current prescribing information separately addresses two or more consecutive missed injection doses. It calls for restarting escalation at a lower dosage to reduce gastrointestinal reactions. Its Medication Guide tells patients who have missed two or more consecutive weeks to contact their healthcare provider about restarting.¹ The prescriber must determine the actual prescription; this guide does not name a restart amount.

Zepbound’s missed-dose section does not provide an equivalent, specific schedule for restarting after several missed weeks.² Its routine late-dose window should not be stretched into approval to return to any previous amount after a long interruption. Contact the prescribing practice for instructions that account for the gap and your treatment history.

Tell the practice why treatment stopped. An insurance delay, an unavailable shipment, a planned procedure and troublesome symptoms give the clinician different information to assess. Our side-effects evidence guide provides background for that conversation; it cannot decide whether your symptoms make restarting appropriate.

Bring a clear timeline to the clinician

A useful message identifies the medicine by brand, injection presentation and prescribed strength. Include the date and time of your last actual injection, each scheduled dose you missed, and whether you took anything late. Distinguish a prescription being issued from a dose actually being administered.

Add why the interruption happened, any symptoms before or during the gap, and whether another clinician has changed your medicines. If the dates are incomplete, say so. A screenshot of a delivery confirmation establishes arrival, not administration; the practice needs your account of what you actually took.

Ask for written instructions covering the next dose, its timing and the follow-up plan. Confirm which practice is responsible if you are moving services. Our provider-transfer checklist explains which records to assemble, including the treatment history a new prescriber may need. A transfer approval or new subscription payment does not itself settle the restart prescription.

Check the product as well as the calendar

Having medication left over does not establish that it remains suitable to use. Ask the dispensing pharmacist about the exact package, storage history and dating if an interruption has left you uncertain. Resolve those questions separately from the missed-dose timing.

A compounded vial has its own prescription and pharmacy instructions. Do not apply these branded timing summaries to it, choose a concentration conversion or infer an injection volume from an old order. Our vial-label guide helps you identify the information to read back to the pharmacist. It does not calculate a replacement dose.

If a device or presentation changed during the gap, ask whether you need fresh administration training. The medication name alone is not enough to confirm that you know how to use the new supply. Bring the package or a clear label photograph to the conversation.

Prevent a refill problem from becoming another interruption

Before leaving the call, establish who will authorize the next prescription, which pharmacy will fill it and when the supply is expected. If payment or delivery remains unresolved, ask the practice what to do if that uncertainty reaches the next scheduled injection. Keep its contact instructions somewhere you can find them without searching old messages.

For a trip, our travel planning guide covers refill arrangements, paperwork and storage questions to settle before departure. For a provider change, keep the outgoing and incoming practices informed about the same timeline. The practical goal is a documented plan for your exact medicine and circumstances, with a clear person to contact if the plan changes.